|
1
|
Hoeper MM, Humbert M, Souza R, Idrees M,
Kawut SM, Sliwa-Hahnle K, Jing ZC and Gibbs JS: A global view of
pulmonary hypertension. Lancet Respir Med. 4:306–322. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mandras SA, Gilkin RJ Jr..Pruett JA and
Raspa S: Pulmonary arterial hypertension: Progress and challenges
in the modern treatment era. Am J Manag Care. 20 Suppl 9:S191–S199.
2014.PubMed/NCBI
|
|
3
|
Weir-McCall JR, Struthers AD, Lipworth BJ
and Houston JG: The role of pulmonary arterial stiffness in COPD.
Respir Med. 109:1381–1390. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Waypa GB, Marks JD, Guzy R, Mungai PT,
Schriewer J, Dokic D and Schumacker PT: Hypoxia triggers
subcellular compartmental redox signaling in vascular smooth muscle
cells. Circ Res. 106:526–535. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schumacker PT: Lung cell hypoxia: Role of
mitochondrial reactive oxygen species signaling in triggering
responses. Proc Am Thorac Soc. 8:477–484. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sylvester JT, Shimoda LA, Aaronson PI and
Ward JP: Hypoxic pulmonary vasoconstriction. Physiol Rev.
92:367–520. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Al Ghouleh I, Khoo NK, Knaus UG,
Griendling KK, Touyz RM, Thannickal VJ, Barchowsky A, Nauseef WM,
Kelley EE, Bauer PM, et al: Oxidases and peroxidases in
cardiovascular and lung disease: New concepts in reactive oxygen
species signaling. Free Radic Biol Med. 51:1271–1288. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vara D and Pula G: Reactive oxygen
species: Physiological roles in the regulation of vascular cells.
Curr Mol Med. 14:1103–1125. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang L, Zhou Y, Li M and Zhu Y: Expression
of hypoxia-inducible factor-1α, endothelin-1 and adrenomedullin in
newborn rats with hypoxia-induced pulmonary hypertension. Exp Ther
Med. 8:335–339. 2014.PubMed/NCBI
|
|
10
|
Han X, Sun S, Zhao M, Cheng X, Chen G, Lin
S, Guan Y and Yu X: Celastrol stimulates hypoxia-inducible factor-1
activity in tumor cells by initiating the ROS/Akt/p70S6K signaling
pathway and enhancing hypoxia-inducible factor-1α protein
synthesis. PLoS One. 9:e1124702014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Frump AL, Goss KN, Vayl A, Albrecht M,
Fisher A, Tursunova R, Fierst J, Whitson J, Cucci AR, Brown MB and
Lahm T: Estradiol improves right ventricular function in rats with
severe angioproliferative pulmonary hypertension: Effects of
endogenous and exogenous sex hormones. Am J Physiol Lung Cell Mol
Physiol. 308:L873–L890. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tofovic SP, Jones T and Petrusevska G:
Dose-dependent therapeutic effects of 2-Methoxyestradiol on
Monocrotaline-Induced pulmonary hypertension and vascular
remodeling. Prilozi. 31:279–295. 2010.PubMed/NCBI
|
|
13
|
Zheng Q, Yuan YD and Zhao J: Effect of
estradiol and its metabolite on hypoxic induced factor-1αand alkane
hydroxylase in experimental rats with ovariectomy and hypoxic
pulmonary hypertension. Chinese Circulation J. 30:884–888.
2015.
|
|
14
|
Yuan M, Duan Z, Sun Y and Yuan Y: Effects
of estrogen on ACE-AngII-AT1 axis in ovariectomy and hypoxic
pulmonary hypertension rats. Zhonghua Yi Xue Za Zhi. 94:1696–1700.
2014.(In Chinese). PubMed/NCBI
|
|
15
|
Shen YX, Xiao K, Liang P, Ma YW and Huang
X: Improvement on the modified Lowry method against interference of
divalent cations in soluble protein measurement. Appl Microbiol
Biotechnol. 97:4167–4178. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Simonneau G, Gatzoulis MA, Adatia I,
Celermajer D, Denton C, Ghofrani A, Sanchez MA Gomez, Kumar R
Krishna, Landzberg M, Machado RF, et al: Updated clinical
classification of pulmonary hypertension. J Am Coll Cardiol. 62
Suppl 25:D34–D41. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Voelkel NF, Gomez-Arroyo J, Abbate A,
Bogaard HJ and Nicolls MR: Pathobiology of pulmonary arterial
hypertension and right ventricular failure. Eur Respir J.
40:1555–1565. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Prabhakar NR and Semenza GL: Adaptive and
maladaptive cardiorespiratory responses to continuous and
intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2.
Physiol Rev. 92:967–1003. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Abud EM, Maylor J, Undem C, Punjabi A,
Zaiman AL, Myers AC, Sylvester JT, Semenza GL and Shimoda LA:
Digoxin inhibits development of hypoxic pulmonary hypertension in
mice. Proc Natl Acad Sci USA. 109:1239–1244. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang GL and Semenza GL: Purification and
characterization of hypoxia-inducible factor 1. J Biol Chem.
270:1230–1237. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Semenza GL: Hypoxia-inducible factor 1:
Regulator of mitochondrial metabolism and mediator of ischemic
preconditioning. Biochim Biophys Acta. 1813:1263–1268. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bruick RK and McKnight SL: A conserved
family of prolyl-4-hydroxylases that modify HIF. Science.
294:1337–1340. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Archer SL, Marsboom G, Kim GH, Zhang HJ,
Toth PT, Svensson EC, Dyck JR, Gomberg-Maitland M, Thébaud B,
Husain AN, et al: Epigenetic attenuation of mitochondrial
superoxide dismutase 2 in pulmonary arterial hypertension: A basis
for excessive cell proliferation and a new therapeutic target.
Circulation. 121:2661–2671. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ahmed LA, Obaid AA, Zaki HF and Agha AM:
Role of oxidative stress, inflammation, nitric oxide and
transforming growth factor-beta in the protective effect of
diosgenin in monocrotaline-induced pulmonary hypertension in rats.
Eur J Pharmacol. 740:379–387. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
He J, Wang M, Jiang Y, Chen Q, Xu S, Xu Q,
Jiang BH and Liu LZ: Chronic arsenic exposure and angiogenesis in
human bronchial epithelial cells via the
ROS/miR-199a-5p/HIF-1α/COX-2 pathway. Environ Health Perspect.
122:255–261. 2014.PubMed/NCBI
|
|
26
|
Sasabe E, Yang Z, Ohno S and Yamamoto T:
Reactive oxygen species produced by the knockdown of
manganese-superoxide dismutase up-regulate hypoxia-inducible
factor-1alpha expression in oral squamous cell carcinoma cells.
Free Radic Biol Med. 48:1321–1329. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fijalkowska I, Xu W, Comhair SA, Janocha
AJ, Mavrakis LA, Krishnamachary B, Zhen L, Mao T, Richter A,
Erzurum SC and Tuder RM: Hypoxia inducible-factor1alpha regulates
the metabolic shift of pulmonary hypertensive endothelial cells. Am
J Pathol. 176:1130–1138. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Duracková Z: Some current insights into
oxidative stress. Physiol Res. 59:459–469. 2010.PubMed/NCBI
|
|
29
|
Li SY, Fu ZJ and Lo AC: Hypoxia-induced
oxidative stress in ischemic retinopathy. Oxid Med Cell Longev.
2012:4267692012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Aggarwal S, Gross CM, Sharma S, Fineman JR
and Black SM: Reactive oxygen species in pulmonary vascular
remodeling. Compr Physiol. 3:1011–1034. 2013.PubMed/NCBI
|
|
31
|
Fukai T and Ushio-Fukai M: Superoxide
dismutases: Role in redox signaling, vascular function, and
diseases. Antioxid Redox Signal. 15:1583–1606. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rabbani ZN, Mi J, Zhang Y, Delong M,
Jackson IL, Fleckenstein K, Salahuddin FK, Zhang X, Clary B,
Anscher MS and Vujaskovic Z: Hypoxia inducible factor 1alpha
signaling in fractionated radiation-induced lung injury: Role of
oxidative stress and tissue hypoxia. Radiat Res. 173:165–174. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Miyamoto N, Mandai M, Takagi H, Suzuma I,
Suzuma K, Koyama S, Otani A, Oh H and Honda Y: Contrasting effect
of estrogen on VEGF induction under different oxygen status and its
role in murine ROP. Invest Ophthalmol Vis Sci. 43:2007–2014.
2002.PubMed/NCBI
|
|
34
|
Wang S, Wang B, Feng Y, Mo M, Du F, Li H
and Yu X: 17β-estradiol ameliorates light-induced retinal damage in
Sprague-Dawley rats by reducing oxidative stress. J Mol Neurosci.
55:141–151. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu Z, Gou Y, Zhang H, Zuo H, Zhang H, Liu
Z and Yao D: Estradiol improves cardiovascular function through
up-regulation of SOD2 on vascular wall. Redox Biol. 3:88–99. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hagen T, D'Amico G, Quintero M,
Palacios-Callender M, Hollis V, Lam F and Moncada S: Inhibition of
mitochondrial respiration by the anticancer agent
2-methoxyestradiol. Biochem Biophys Res Commun. 322:923–929. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ma L, Li G, Zhu H, Dong X, Zhao D, Jiang
X, Li J, Qiao H, Ni S and Sun X: 2-Methoxyestradiol synergizes with
sorafenib to suppress hepatocellular carcinoma by simultaneously
dysregulating hypoxia-inducible factor-1 and −2. Cancer Lett.
355:96–105. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Verenich S and Gerk PM: Therapeutic
promises of 2-methoxyestradiol and its drug disposition challenges.
Mol Pharm. 7:2030–2039. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Basini G, Santini SE and Grasselli F:
2-Methoxyestradiol inhibits superoxide anion generation while it
enhances superoxide dismutase activity in swine granulosa cells.
Ann N Y Acad Sci. 1091:34–40. 2006. View Article : Google Scholar : PubMed/NCBI
|
